• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

ROCHE I (RO)

Sell: 370.00 CHF|Buy: 378.00 CHF|Change: 1.20 (-0.32%)

Open 

376.60 CHF

Previous close 

376.40 CHF

Trade high 

377.80 CHF

Volume 

23,317

Year high 

383.00 CHF

Year low 

264.60 CHF

Dividend yield 

2.61%

Market capitalisation 

298.95 bn CHF

P/E ratio 

24.47

ISIN 

CH0012032113

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Share price

Performance 25/09/2026

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

Total return (%)
ROCHE I- 0.32
More...

Company profile

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 40% of pharmaceutical sales, and centralized and point-of-care diagnostics for two-thirds of diagnostic-related sales.

Sector 

Healthcare

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.